跳至主要内容
临床试验/NCT04376281
NCT04376281已完成不适用

The Effect of Norepinephrine on Blood Volume Cardiac , Output and Systemic Filling Pressure in Patients Undergoing Liver Transplant .

Cairo University1 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2019年12月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
31
试验地点
1
主要终点
The effect of Noradrenaline on change of cardiac output .

研究概览

简要总结

Early administration of NE in liver transplant recipient might enhance cardiac output through an increase in cardiac preload .

详细描述

The derangement of circulatory blood volume in patients with liver cirrhosis makes intraoperative fluid management during liver transplant is challenging . Cirrhotic patients not only have large blood volume but abnormal blood volume distribution, with a substantial fraction of this volume in the splanchnic circulation (. These hemodynamic changes render volume loading in these patients has little impact on CO because a large proportion of infused fluid is shifted to the splanchnic system . In addition, patients with liver cirrhosis is similar to septic patients who have increased total vascular compliance which may cause pooling of blood in venous pool. Several studies in patients with sepsis found that use of low dose vasopressor may convert unstressed blood volume (i.e the amount of blood not causing pressure on the vessels) to stressed volume (i.e additional blood causing a distending pressure on the vascular walls and reflects the effective circulating volume) . However, no previous studies tested the effect of using norepinephrine (NE) on venous return and cardiac preload in patients undergoing liver transplant. An obvious advantage of this possibility is that NE will be used instead of true fluid replacement which may minimize fluid replacement during operation.

Recently, a method was described to estimate the changes in intravascular volume and vascular capacitance by calculating mean systemic filling pressure (MSFP) . MSFP is the driving pressure in venous return, and it allows calculation of the arterial and venous components of systemic vascular resistance .

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All Adults (age > 18 years) patients undergoing living donor liver transplant (LDLT) will be considered for inclusion in the study..

排除标准

  • Patients less than 18 years.
  • Patients undergoing liver transplantation for acute liver failure .
  • All Chronic Hypertensive patients on medication , whether controlled on not controlled
  • Those with high risk of post transplant renal dysfunction (serum creatinine >1.5 mg/dL at time of transplant)

研究组 & 干预措施

Noradrenaline group

Experimental

干预措施: Noradrenaline (Drug)

结局指标

主要结局

The effect of Noradrenaline on change of cardiac output .

时间窗: along the procedure ; from skin incision to the end of surgery

The effect of Noradrenaline on change of cardiac output .

次要结局

  • The effect of NE on central venous pressure .(along the procedure ; from skin incision to the end of surgery)
  • The effect of NE on mean systemic filling pressure .(along the procedure ; from skin incision to the end of surgery)
  • The effect of NE on venous return .(along the procedure ; from skin incision to the end of surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Amr Hussein Sayed

MD

Cairo University

研究点 (1)

Loading locations...

相似试验